Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tsao

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Cancer Research|November 24, 2001
KIT activation is a ubiquitous feature of gastrointestinal stromal tumorsB P Rubin, S Singer, C Tsao, et al.
Cancer Research|October 21, 2016
Transcription Factor ZBP-89 Drives a Feedforward Loop of β-Catenin Expression in Colorectal CancerBryan E Essien, Sinju Sundaresan, Ramon Ocadiz-Ruiz, et al.
Neurology|September 11, 2002
Benefit of interferon beta-1a on MSFC progression in secondary progressive MSJ A Cohen, G R Cutter, J S Fischer, et al.
The Journal of Biological Chemistry|May 1, 2001
Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brainW Qu, J A Bradbury, C C Tsao, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptorGregori J Morriello, Gary Chicchi, Tricia Johnson, et al.
Virus Research|August 26, 2000
Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998S R Shih, M S Ho, K H Lin, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE studyM Tempero, D-Y Oh, J Tabernero, et al.
Pediatric Research|June 23, 2009
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe diseasePriya S Kishnani, Deya Corzo, Nancy D Leslie, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonistsGregori J Morriello, Sander G Mills, Tricia Johnson, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Cancer Research|November 24, 2001
KIT activation is a ubiquitous feature of gastrointestinal stromal tumorsB P Rubin, S Singer, C Tsao, et al.
Cancer Research|October 21, 2016
Transcription Factor ZBP-89 Drives a Feedforward Loop of β-Catenin Expression in Colorectal CancerBryan E Essien, Sinju Sundaresan, Ramon Ocadiz-Ruiz, et al.
Neurology|September 11, 2002
Benefit of interferon beta-1a on MSFC progression in secondary progressive MSJ A Cohen, G R Cutter, J S Fischer, et al.
The Journal of Biological Chemistry|May 1, 2001
Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brainW Qu, J A Bradbury, C C Tsao, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptorGregori J Morriello, Gary Chicchi, Tricia Johnson, et al.
Virus Research|August 26, 2000
Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998S R Shih, M S Ho, K H Lin, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonistsGregori J Morriello, Robert J Devita, Sander G Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE studyM Tempero, D-Y Oh, J Tabernero, et al.
Pediatric Research|June 23, 2009
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe diseasePriya S Kishnani, Deya Corzo, Nancy D Leslie, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonistsGregori J Morriello, Sander G Mills, Tricia Johnson, et al.
Pageof 18